Nutrients · Nov 14, 2026
C-Reactive Protein-to-Albumin Ratio at the Inflammation-Nutrition Interface: Clinical Evidence, Nutritional Relevance, and Translational Perspectives
By Khan MI
The C-reactive protein-to-albumin ratio (CAR) is a readily available composite biomarker reflecting systemic inflammatory activity and changes in circulating albumin, but its nutritional interpretation and clinical utility remain incompletely defined. This narrative review critically examines the biological basis, nutritional and functional relevance, clinical evidence, comparative performance, methodological limitations, and potential precision-nutrition role of CAR. PubMed/MEDLINE, Embase, Scopus, and Web of Science Core Collection were searched from database inception through 20 August 2026, supplemented by citation tracking and relevant consensus and methodological literature. Across diverse clinical populations, higher CAR has generally been associated with adverse outcomes, while nutrition- and function-focused studies link elevated CAR with nutritional risk, frailty, sarcopenia, and impaired physical performance. Reported discrimination for nutrition- and function-related outcomes has been context dependent, with selected area under curve (AUCs) ranging from 0.619 to 0.814. Current evidence does not establish CAR as consistently superior to CRP, albumin, or established inflammatory and nutrition-related indices. Interpretation is further limited by heterogeneity in assay and calculation conventions, sampling time, organ dysfunction, fluid status, study-derived cut-offs, and limited external validation. CAR should therefore be regarded as an inflammation-associated marker of nutritional and physiological vulnerability rather than a diagnostic marker of malnutrition. Future research should prioritize standardized measurement, prospective construct validation, longitudinal and multicentre validation, incremental and clinical-utility evaluation, and randomized assessment of CAR-by-intervention effects before precision-nutrition treatment selection is considered.